Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 275 entries
Sorted by: Best Match Show Resources per page
Antidotes to Arsenic.

British medical journal

[No authors listed]
PMID: 20785150
Br Med J. 1943 Nov 27;2(4325):681-2.

No abstract available.

Cite
Antidotes to Arsenic. Br Med J. 1943;2(4325):681-2
(1943). Antidotes to Arsenic. British medical journal, 2(4325), 681-2.
"Antidotes to Arsenic." British medical journal vol. 2,4325 (1943): 681-2.
Antidotes to Arsenic. Br Med J. 1943 Nov 27;2(4325):681-2. PMID: 20785150; PMCID: PMC2285475.
Copy Download .nbib Format: NLM
Safety of new oral anticoagulant drugs: a perspective.

Therapeutic advances in drug safety

Vílchez JA, Gallego P, Lip GY.
PMID: 25083259
Ther Adv Drug Saf. 2014 Feb;5(1):8-20. doi: 10.1177/2042098613507945.

The recent development of new oral anticoagulants (NOACs) offers the possibility of efficacy, relative safety and convenience compared with warfarin. This could lead to greater patient compliance, with easier management and improved provision of thromboprophylaxis. Safety whilst using NOACs...

Cite
Vílchez JA, Gallego P, Lip GY. Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf. 2014;5(1):8-20doi: 10.1177/2042098613507945.
Vílchez, J. A., Gallego, P., & Lip, G. Y. (2014). Safety of new oral anticoagulant drugs: a perspective. Therapeutic advances in drug safety, 5(1), 8-20. https://doi.org/10.1177/2042098613507945
Vílchez, Juan Antonio, et al. "Safety of new oral anticoagulant drugs: a perspective." Therapeutic advances in drug safety vol. 5,1 (2014): 8-20. doi: https://doi.org/10.1177/2042098613507945
Vílchez JA, Gallego P, Lip GY. Safety of new oral anticoagulant drugs: a perspective. Ther Adv Drug Saf. 2014 Feb;5(1):8-20. doi: 10.1177/2042098613507945. PMID: 25083259; PMCID: PMC4110875.
Copy Download .nbib Format: NLM
Of Poisons and Antidotes in Polypropylene Catalysis.

Angewandte Chemie (International ed. in English)

Yu Y, Busico V, Budzelaar PH, Vittoria A, Cipullo R.
PMID: 27243600
Angew Chem Int Ed Engl. 2016 Jul 18;55(30):8590-4. doi: 10.1002/anie.201602485. Epub 2016 May 31.

Quenched-flow studies of MgCl2 -supported Ziegler-Natta catalysts were combined for the first time with (13) C NMR fingerprinting of the nascent polymer and conclusively proved that, depending on the catalyst formulation, propene polymerization can be slowed down significantly by...

Cite
Yu Y, Busico V, Budzelaar PH, et al. Of Poisons and Antidotes in Polypropylene Catalysis. Angew Chem Int Ed Engl. 2016;55(30):8590-4doi: 10.1002/anie.201602485.
Yu, Y., Busico, V., Budzelaar, P. H., Vittoria, A., & Cipullo, R. (2016). Of Poisons and Antidotes in Polypropylene Catalysis. Angewandte Chemie (International ed. in English), 55(30), 8590-4. https://doi.org/10.1002/anie.201602485
Yu, Yue, et al. "Of Poisons and Antidotes in Polypropylene Catalysis." Angewandte Chemie (International ed. in English) vol. 55,30 (2016): 8590-4. doi: https://doi.org/10.1002/anie.201602485
Yu Y, Busico V, Budzelaar PH, Vittoria A, Cipullo R. Of Poisons and Antidotes in Polypropylene Catalysis. Angew Chem Int Ed Engl. 2016 Jul 18;55(30):8590-4. doi: 10.1002/anie.201602485. Epub 2016 May 31. PMID: 27243600.
Copy Download .nbib Format: NLM
Antidotes for patients taking novel oral anti-coagulants.

World journal of emergency medicine

Yip SW, Chan YC.
PMID: 26693269
World J Emerg Med. 2015;6(4):311-2. doi: 10.5847/wjem.j.1920-8642.2015.04.012.

No abstract available.

Cite
Yip SW, Chan YC. Antidotes for patients taking novel oral anti-coagulants. World J Emerg Med. 2015;6(4):311-2doi: 10.5847/wjem.j.1920-8642.2015.04.012.
Yip, S. W., & Chan, Y. C. (2015). Antidotes for patients taking novel oral anti-coagulants. World journal of emergency medicine, 6(4), 311-2. https://doi.org/10.5847/wjem.j.1920-8642.2015.04.012
Yip, Stefanie W, and Chan, Yiu Che. "Antidotes for patients taking novel oral anti-coagulants." World journal of emergency medicine vol. 6,4 (2015): 311-2. doi: https://doi.org/10.5847/wjem.j.1920-8642.2015.04.012
Yip SW, Chan YC. Antidotes for patients taking novel oral anti-coagulants. World J Emerg Med. 2015;6(4):311-2. doi: 10.5847/wjem.j.1920-8642.2015.04.012. PMID: 26693269; PMCID: PMC4677077.
Copy Download .nbib Format: NLM
DOACs - advances and limitations in real world.

Thrombosis journal

Lee LH.
PMID: 27766043
Thromb J. 2016 Oct 04;14:17. doi: 10.1186/s12959-016-0111-3. eCollection 2016.

The group of new oral anticoagulants or NOACs, now termed direct oral anticoagulants or DOACs, with their favourable results from large scale phase III clinical trials, represent a major advancement and expanded armamentarium in antithrombotic therapy. Dabigatran, rivaroxaban, apixaban...

Cite
Lee LH. DOACs - advances and limitations in real world. Thromb J. 2016;14:17doi: 10.1186/s12959-016-0111-3.
Lee, L. H. (2016). DOACs - advances and limitations in real world. Thrombosis journal, 1417. https://doi.org/10.1186/s12959-016-0111-3
Lee, Lai Heng. "DOACs - advances and limitations in real world." Thrombosis journal vol. 14 (2016): 17. doi: https://doi.org/10.1186/s12959-016-0111-3
Lee LH. DOACs - advances and limitations in real world. Thromb J. 2016 Oct 04;14:17. doi: 10.1186/s12959-016-0111-3. eCollection 2016. PMID: 27766043; PMCID: PMC5056491.
Copy Download .nbib Format: NLM
New guidance on antidotes to poison.

Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association

[No authors listed]
PMID: 27715160
Emerg Nurse. 2006 Sep 01;14(5):3. doi: 10.7748/en.14.5.3.s9.

The British Association for Emergency Medicine and Guy's and St Thomas' Poisons Unit, London, have published guidance on poison antidotes.

Cite
New guidance on antidotes to poison. Emerg Nurse. 2006;14(5):3doi: 10.7748/en.14.5.3.s9.
(2006). New guidance on antidotes to poison. Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association, 14(5), 3. https://doi.org/10.7748/en.14.5.3.s9
"New guidance on antidotes to poison." Emergency nurse : the journal of the RCN Accident and Emergency Nursing Association vol. 14,5 (2006): 3. doi: https://doi.org/10.7748/en.14.5.3.s9
New guidance on antidotes to poison. Emerg Nurse. 2006 Sep 01;14(5):3. doi: 10.7748/en.14.5.3.s9. PMID: 27715160.
Copy Download .nbib Format: NLM
The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro.

PloS one

Golderman V, Shavit-Stein E, Tamarin I, Rosman Y, Shrot S, Rosenberg N, Maggio N, Chapman J, Eisenkraft A.
PMID: 27689805
PLoS One. 2016 Sep 30;11(9):e0163787. doi: 10.1371/journal.pone.0163787. eCollection 2016.

Organophosphates (OPs) are potentially able to affect serine proteases by reacting with their active site. The potential effects of OPs on coagulation factors such as thrombin and on coagulation tests have been only partially characterized and potential interactions with...

Cite
Golderman V, Shavit-Stein E, Tamarin I, et al. The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro. PLoS One. 2016;11(9):e0163787doi: 10.1371/journal.pone.0163787.
Golderman, V., Shavit-Stein, E., Tamarin, I., Rosman, Y., Shrot, S., Rosenberg, N., Maggio, N., Chapman, J., & Eisenkraft, A. (2016). The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro. PloS one, 11(9), e0163787. https://doi.org/10.1371/journal.pone.0163787
Golderman, Valery, et al. "The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro." PloS one vol. 11,9 (2016): e0163787. doi: https://doi.org/10.1371/journal.pone.0163787
Golderman V, Shavit-Stein E, Tamarin I, Rosman Y, Shrot S, Rosenberg N, Maggio N, Chapman J, Eisenkraft A. The Organophosphate Paraoxon and Its Antidote Obidoxime Inhibit Thrombin Activity and Affect Coagulation In Vitro. PLoS One. 2016 Sep 30;11(9):e0163787. doi: 10.1371/journal.pone.0163787. eCollection 2016. PMID: 27689805; PMCID: PMC5045196.
Copy Download .nbib Format: NLM
Acute Cyanide Poisoning: Hydroxocobalamin and Sodium Thiosulfate Treatments with Two Outcomes following One Exposure Event.

Case reports in medicine

Meillier A, Heller C.
PMID: 26543483
Case Rep Med. 2015;2015:217951. doi: 10.1155/2015/217951. Epub 2015 Oct 12.

Cyanide is rapidly reacting and causes arrest of aerobic metabolism. The symptoms are diffuse and lethal and require high clinical suspicion. Remediation of symptoms and mortality is highly dependent on quick treatment with a cyanide antidote. Presently, there are...

Cite
Meillier A, Heller C. Acute Cyanide Poisoning: Hydroxocobalamin and Sodium Thiosulfate Treatments with Two Outcomes following One Exposure Event. Case Rep Med. 2015;2015:217951doi: 10.1155/2015/217951.
Meillier, A., & Heller, C. (2015). Acute Cyanide Poisoning: Hydroxocobalamin and Sodium Thiosulfate Treatments with Two Outcomes following One Exposure Event. Case reports in medicine, 2015217951. https://doi.org/10.1155/2015/217951
Meillier, Andrew, and Heller, Cara. "Acute Cyanide Poisoning: Hydroxocobalamin and Sodium Thiosulfate Treatments with Two Outcomes following One Exposure Event." Case reports in medicine vol. 2015 (2015): 217951. doi: https://doi.org/10.1155/2015/217951
Meillier A, Heller C. Acute Cyanide Poisoning: Hydroxocobalamin and Sodium Thiosulfate Treatments with Two Outcomes following One Exposure Event. Case Rep Med. 2015;2015:217951. doi: 10.1155/2015/217951. Epub 2015 Oct 12. PMID: 26543483; PMCID: PMC4620268.
Copy Download .nbib Format: NLM
The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose.

Open access emergency medicine : OAEM

Hunter LJ, Wood DM, Dargan PI.
PMID: 27147851
Open Access Emerg Med. 2011 Jul 06;3:39-48. doi: 10.2147/OAEM.S22795. eCollection 2011.

The nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for their analgesic, anti-inflammatory and antipyretic actions. They are commonly taken in overdose in many areas of the world. The majority of patients with acute NSAID overdose will remain asymptomatic or...

Cite
Hunter LJ, Wood DM, Dargan PI. The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose. Open Access Emerg Med. 2011;3:39-48doi: 10.2147/OAEM.S22795.
Hunter, L. J., Wood, D. M., & Dargan, P. I. (2011). The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose. Open access emergency medicine : OAEM, 339-48. https://doi.org/10.2147/OAEM.S22795
Hunter, Laura J, et al. "The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose." Open access emergency medicine : OAEM vol. 3 (2011): 39-48. doi: https://doi.org/10.2147/OAEM.S22795
Hunter LJ, Wood DM, Dargan PI. The patterns of toxicity and management of acute nonsteroidal anti-inflammatory drug (NSAID) overdose. Open Access Emerg Med. 2011 Jul 06;3:39-48. doi: 10.2147/OAEM.S22795. eCollection 2011. PMID: 27147851; PMCID: PMC4753966.
Copy Download .nbib Format: NLM
Clinical toxicology: part II. Diagnosis and management of uncommon poisonings.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine

Worthley LI.
PMID: 16573430
Crit Care Resusc. 2002 Sep;4(3):216-30.

OBJECTIVE: To review the diagnosis and management of drug overdose and poisonings in a two-part presentation.DATA SOURCES: A review of articles reported on drug overdose and poisonings.SUMMARY OF REVIEW: In patients who attempt suicide it is usual for the...

Cite
Worthley LI. Clinical toxicology: part II. Diagnosis and management of uncommon poisonings. Crit Care Resusc. 2002;4(3):216-30
Worthley, L. I. (2002). Clinical toxicology: part II. Diagnosis and management of uncommon poisonings. Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine, 4(3), 216-30.
Worthley, L I G. "Clinical toxicology: part II. Diagnosis and management of uncommon poisonings." Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine vol. 4,3 (2002): 216-30.
Worthley LI. Clinical toxicology: part II. Diagnosis and management of uncommon poisonings. Crit Care Resusc. 2002 Sep;4(3):216-30. PMID: 16573430.
Copy Download .nbib Format: NLM
Pharmacological Screening of Plants Recommended by Folk Medicine as Snake Venom Antidotes; IV. Protection against Jararaca Venom by Isolated Constituents1.

Planta medica

Pereira NA, Pereira BM, Nascimento MC, Parente JP, Mors WB.
PMID: 17236028
Planta Med. 1994 Apr;60(2):99-100. doi: 10.1055/s-2006-959425.

Fifteen Compounds, isolated from plants reputed as snake venom antidotes, belonging to different classes of natural products, were shown to protect mice to a significant degree against the lethal action of the venom of BOTHROPS JARARACA snakes. Administration was...

Cite
Pereira NA, Pereira BM, Nascimento MC, et al. Pharmacological Screening of Plants Recommended by Folk Medicine as Snake Venom Antidotes; IV. Protection against Jararaca Venom by Isolated Constituents1. Planta Med. 1994;60(2):99-100doi: 10.1055/s-2006-959425.
Pereira, N. A., Pereira, B. M., Nascimento, M. C., Parente, J. P., & Mors, W. B. (1994). Pharmacological Screening of Plants Recommended by Folk Medicine as Snake Venom Antidotes; IV. Protection against Jararaca Venom by Isolated Constituents1. Planta medica, 60(2), 99-100. https://doi.org/10.1055/s-2006-959425
Pereira, N A, et al. "Pharmacological Screening of Plants Recommended by Folk Medicine as Snake Venom Antidotes; IV. Protection against Jararaca Venom by Isolated Constituents1." Planta medica vol. 60,2 (1994): 99-100. doi: https://doi.org/10.1055/s-2006-959425
Pereira NA, Pereira BM, Nascimento MC, Parente JP, Mors WB. Pharmacological Screening of Plants Recommended by Folk Medicine as Snake Venom Antidotes; IV. Protection against Jararaca Venom by Isolated Constituents1. Planta Med. 1994 Apr;60(2):99-100. doi: 10.1055/s-2006-959425. PMID: 17236028.
Copy Download .nbib Format: NLM
Concerning cyanide antidotes.

California and western medicine

Geiger JC.
PMID: 18743484
Cal West Med. 1935 Dec;43(6):457.

No abstract available.

Cite
Geiger JC. Concerning cyanide antidotes. Cal West Med. 1935;43(6):457
Geiger, J. C. (1935). Concerning cyanide antidotes. California and western medicine, 43(6), 457.
Geiger, J C. "Concerning cyanide antidotes." California and western medicine vol. 43,6 (1935): 457.
Geiger JC. Concerning cyanide antidotes. Cal West Med. 1935 Dec;43(6):457. PMID: 18743484; PMCID: PMC1760021.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 275 entries